Dr. Reddy's Laboratories Ltd. have entered into an exclusive agreement with a global medical technology company, Integra LifeSciences Holdings Corporation.
Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care.
As part of the agreement two of Integra's products, DuraGen Plus® Dural Regeneration Matrix and Suturable DuraGenTM Dural Regeneration Matrix, will be marketed and distributed by Hyderabad based Dr. Reddy's for use by patients in India.
The DuraGen product line offers Duraplasty Solutions meant for repairing the thick membrane surrounding the brain and spinal cord, called dura mater. It contains the cerebrospinal fluid (CSF).
The DuraGen products by Integra have been implanted in more than 1.8 million patients worldwide. Integra plans to continue expanding patient access globally with the help of this collaboration.
Dr. Reddy's laboratories intend on building their presence in the segment of regenerative technologies and on making a difference to the lives of patients undergoing neurosurgery.